Redwood Investments, LLC

Redwood Investments, LLC is a SEC-registered investment advisory firm headquartered in Boston, Massachusetts, filing with the SEC under CIK #0001384058. Operating from one of America's most established institutional investment management centers, the firm specializes in actively managed small and mid-cap (SMID-cap) equity strategies serving institutional clients and sub-advisory mandates that demand rigorous bottom-up stock selection within the smaller capitalization segments of the U.S. equity market. The firm was founded by Michael Nawrocki, who serves as Managing Partner and Chief Investment Officer, bringing deep expertise in SMID-cap equity investing. The investment team includes Jennifer Pawloski as Partner and Senior Portfolio Manager, alongside William Buoni as Partner and Portfolio Manager. This experienced multi-person investment team enables collaborative research coverage across the broader SMID-cap universe while maintaining philosophical coherence under the CIO's leadership. Boston's deep institutional investment management heritage provides Redwood Investments with access to institutional research infrastructure, talented investment professionals, and the concentration of asset owners and consultants that drive institutional mandate allocation. The city's legacy as a center for fundamental equity research supports the firm's bottom-up, research-intensive approach to SMID-cap investing. With 13F filing history extending back to 2006, Redwood Investments provides nearly two decades of quarterly transparency into its U.S. equity holdings. This exceptional track record spans multiple complete market cycles including the 2007-2009 Global Financial Crisis, the extended bull market recovery, pandemic disruption, and recent inflationary volatility. The platform's 13F History tools enable researchers to conduct comprehensive longitudinal analysis of the firm's SMID-cap portfolio construction across dramatically different market environments.

Redwood Investments, LLC employs a growth-oriented investment philosophy specializing in the small and mid-capitalization segment of the U.S. equity market. The firm's SMID-cap focus targets companies in the emerging growth phase of their corporate lifecycle—businesses transitioning from small-cap entrepreneurial enterprises into established mid-cap market participants with proven business models and expanding addressable markets. The investment approach reflects intensive bottom-up fundamental research where security selection identifies companies with accelerating revenue growth, expanding margins, competitive moat development, and capable management teams executing on identifiable growth strategies. 13F Portfolio Composition analysis across the firm's nearly two-decade filing history reveals diversified sector exposure across technology, healthcare, and industrials—the sectors where SMID-cap growth opportunities most frequently concentrate. Technology positions target emerging software platforms, cybersecurity innovators, cloud infrastructure providers, and semiconductor companies in the early stages of product cycle acceleration. Healthcare allocations focus on specialty pharmaceutical, medical device, and life sciences companies with differentiated product pipelines and growth catalysts. Industrial holdings capture specialty manufacturing, environmental services, and infrastructure-related businesses benefiting from sector-specific tailwinds. Historical filing patterns indicate moderate to high portfolio turnover, consistent with SMID-cap growth investing where position management requires ongoing evaluation of growth trajectory sustainability and timely adjustment as companies mature through the capitalization spectrum. Positions initiated in the small-cap range may be reduced or exited as companies grow into large-cap territory, maintaining portfolio alignment with the SMID-cap mandate. Users can examine the firm's extensive Sector Allocation History spanning nearly two decades to observe how technology, healthcare, and industrials weightings have evolved across market cycles and opportunity set dynamics within the SMID-cap universe.

Redwood Investments, LLC represents a well-established Boston-based SMID-cap growth specialist with a nearly two-decade 13F filing history under CIK #0001384058. Under the leadership of founder Michael Nawrocki alongside partners Jennifer Pawloski and William Buoni, the firm has built a focused practice executing bottom-up fundamental growth investing within the smaller capitalization equity universe. The exceptional length and institutional nature of the filing record provide analytical depth rarely available among specialized SMID-cap managers. Key analytical dimensions include Annualized Return (CAGR) measurement through portfolio simulation spanning multiple complete market cycles, Sortino Ratio evaluation to assess downside-risk-adjusted compounding efficiency given the elevated volatility inherent in SMID-cap growth, and Top 10 Holdings Concentration analysis to understand conviction expression and diversification across the firm's extensive investment history. For allocators evaluating SMID-cap growth specialists with institutional pedigree and genuinely long-term track records, the disclosed 13F history enables detailed examination of strategy consistency, capitalization drift management, sector allocation evolution, and crisis navigation across fundamentally different market regimes. The Boston location and institutional client orientation confirm the operational infrastructure expected for sub-advisory mandates. The SMID-cap growth specialization creates identifiable exposure to specific market capitalization and growth factor dynamics. How does the portfolio's capital trajectory compare during small-cap versus mid-cap leadership cycles, and does the firm's stock selection discipline generate measurable alpha within the SMID-cap growth universe relative to passive SMID-cap exposure across complete market cycles?

The SMID-cap growth specialization positions Redwood Investments' portfolio for elevated volatility relative to large-cap benchmarks. Smaller capitalization equities exhibit greater price variability due to lower trading liquidity, higher earnings sensitivity, and greater vulnerability to competitive and operational risks. The growth orientation amplifies these characteristics by selecting companies in the higher-growth, higher-multiple segment of the SMID-cap universe. Max Drawdown Depth analysis across the firm's nearly two-decade filing history provides exceptionally rich insight into stress behavior through multiple severe drawdown episodes. The 2008-2009 financial crisis was particularly impactful for SMID-cap growth strategies where liquidity withdrawal and risk-off positioning produced amplified drawdowns. Subsequent stress periods including the 2011 correction, 2015-2016 industrial recession, 2018 fourth quarter sell-off, 2020 pandemic crash, and 2022 growth factor drawdown offer comprehensive stress testing across diverse catalysts. Volatility Profile assessment reveals the strategy's elevated beta characteristics inherent in SMID-cap growth investing, with expected variability meaningfully above broad market indices. Within SMID-cap universes, the growth orientation introduces additional factor-specific risk during periods when value and quality factors outperform growth characteristics. The moderate to high turnover profile means portfolio risk characteristics can evolve between reporting periods as positions are adjusted based on growth trajectory developments and capitalization migration. Downside Capture Ratio measurement across multiple bear markets provides statistically meaningful assessment of the strategy's drawdown behavior relative to SMID-cap benchmarks. Liquidity risk represents a persistent SMID-cap consideration, as smaller capitalization positions may face wider bid-ask spreads and potential difficulty executing trades during market stress without adverse price impact.